This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research:
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the mice model market. The secondary sources used for this study include International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research:
Extensive primary research was conducted after acquiring basic knowledge about the global mice model market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & biopharmaceutical and biotechnology companies, CROs, and academic & research institutes) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and the Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach:
-
The key players in the industry and market have been identified through extensive secondary research.
-
The revenues generated from the mice model market business of leading players have been determined through primary and secondary research.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation:
To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition:
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of the human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to genetic build-up.
The scope of the report encompasses mice models and associated services offered by companies like Charles River Laboratories and THE JACKSON LABORATORY.
Stakeholders:
-
Manufacturers and distributors of mice model products
-
Mice model service providers
-
Pharmaceutical and biotechnology companies
-
Market research and consulting firms
-
R&D centers
-
Researchers and scientists
-
Regulatory authorities & institutions
-
Academic & research institutes
-
CROs & CDMOs
Report Objectives:
-
To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, end user, and region
-
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
-
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
-
To profile the key players in the global mice model market and comprehensively analyze their core competencies and market shares
-
To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the mice model market
-
To benchmark players in the mice model market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis:
-
Further breakdown of the Rest of Europe mice model market, by country
-
Further breakdown of the Rest of Asia Pacific mice model market, by country
-
Further breakdown of the Rest of Latin America mice model market, by country
-
Further breakdown of the Rest of Middle East mice model market, by country
-
Further breakdown of the Rest of GCC Countries mice model market, by country
Company Information:
-
Detailed analysis and profiling of additional market players (up to five)
Segment Analysis:
-
Further breakdown of the other technologies and other therapeutic area into subsegments
-
Cross-segment analysis
Growth opportunities and latent adjacency in Mice Model Market